A formal comparison of different methods for establishing cut points to distinguish positive and negative samples in immunoassays

Journal of Pharmaceutical and Biomedical Analysis

Volumn 55, Issue 5, 2011, Pages 1148-1156

  Jaki, Thomas ^a   Lawo, John Philip ^b   Wolfsegger, Martin J ^b   Singer, Julia ^b   Allacher, Peter ^b   Horling, Frank ^b  

^a LANCASTER UNIVERSITY   (United Kingdom)

^b BAXTER INNOVATIONS GMBH   (Austria)

Author keywords

Anti drug antibody; Cut point; ELISA; Immunoassay; Immunogenicity

Indexed keywords

ANALYTIC METHOD; ARTICLE; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; PARAMETRIC TEST; PERFORMANCE; PRIORITY JOURNAL; PUBLICATION; SAMPLE;

ALGORITHMS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, NEUTRALIZING; BIOLOGICAL ASSAY; BIOLOGICAL PRODUCTS; CHEMISTRY TECHNIQUES, ANALYTICAL; CHEMISTRY, PHARMACEUTICAL; COMPUTER SIMULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOASSAY; MODELS, STATISTICAL; PHARMACEUTICAL PREPARATIONS;

EID: 79956124888     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.04.006     Document Type: Article

References (18)

1. Committee for medicinal products for human use, Guideline on immunogenicity assessment of biotechnology derived therapeutic proteins, European Medicines Agency (2007). URL: (last visited 29.10.2010). http://www.ema.europa.eu/docs/enGB/documentlibrary/Scientificguideline/2009/0.
2. Mire-Sluis A., Barrett Y., Devanarayan V., Koren E., Liu H., Maia M., Parish T., Scott G., Shankar G., Shores E., Swanson S., Taniguchi G., Wierda D., Zucker-man L. Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products. J. Immunol. Methods 2004, 289:1-16.
3. Gupta S., Indelicato S., Jethwa V., Kawabata T., Kelley M., Mire-Sluis A., Richards S., Rup B., Shores E., Swanson S., Wakshull E. Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics. J. Immunol. Methods 2007, 321:1-18.
4. Shankar G, Devanarayan V., Amaravadi L., Barrett Y., Bowsher R., Finco-Kent D., Fiscella M., Gorovits B., Kirschner S., Moxness M., Parish T., Quarmby V., Smith H., Smith W., Zuckerman L., Koren E. Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products. J. Pharma. Biomed. Anal. 2008, 48:1267-1281.
5. Koren E., Smith H., Shores E., Shankar G., Finco-Kent D., Rup B., Barrett Y.-C., Devanarayan V., Gorovits B., Gupta S., Parish T., Quarmby V., Moxness M., Swanson S., Taniguchi G., Zuckerman L., Stebbins C., Mire-Sluis A. Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products. J. Immunol. Methods 2008, 333:1-9.
6. Shapiro S., Wilk M. An analysis of variance test for normality (complete samples). Biometrika 1965, 52:591-611.
7. Chambers J., Cleveland W., Kleiner B., Tukey P. Graphical Methods for Data Analysis 1983, Wadsworth & Brooks/Cole.
8. Bailey S. Subchronic toxicity studies. Design and Analysis of Animal Studies in Pharmaceutical Development 1998, 135-196. Marcel Dekker, New York. S. Chow, J. Liu (Eds.).
9. Hennig C. Falsification of propensity models by statistical tests and the goodness-of-fit paradox. Philos. Math. 2007, 15:166-192.
10. Wolfsegger M., Jaki T., Dietrich B., Kunzler J., Barker K. A note on statistical analysis of organ weights in non-clinical toxicological studies. Toxicol. Appl. Pharmacol. 2009, 240:117-122.
11. Wedel M., Desarbo W. A review of recent developments in latent class regression models. Advanced Methods of Marketing Research 1994, 352-388. Blackwell Publishers, Cambridge. R. Bagozzi (Ed.).
12. Van Horn M.L., Jaki T., Ramey S.L., Masyn K., Smith J.A., Antaramian S. Assessing differential effects: Applying regression mixture models to identify variations in the influence of family resources on academic achievement. Dev. Psychol. 2009, 45:1298-1313.
13. McLachlan G., Peel D. Finite Mixture Models 2000, John Wiley & Sons, Inc., New York.
14. R Development Core Team, R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria, 2010, ISBN 3-900051-07-0, URL: http://www.%20r-project.org/.
15. M. Stasinopoulos, B. Rigby, gamlss.mx: a GAMLSS add on package for fitting mixture distributions, r package version 4.0-4, 2010, URL: http://cran.r-project.org/package=gamlss.mx.
16. C. Jackson, msm: multi-state Markov and hidden Markov models in continuous time, r package version 0.9.7, 2010, URL: http://cran.r-project.org/package=msm.
17. Schwarz G. Estimating the dimension of a model. Ann. Stat. 1978, 6:461-464.
18. Ward J. Hierarchical grouping to optimize an objective function. J. Am. Stat. Assoc. 1963, 58:236-244.